RSS-Feed abonnieren
DOI: 10.1055/s-0041-1737943
A Novel Thiazolidine Scaffold that Inhibits O-GlcNAcase (OGA)
Autoren
Bicyclic Picomolar OGA Inhibitors Enable Chemoproteomic Mapping of Its Endogenous Post-Translational Modifications.
J. Am. Chem. Soc. 2022;
144: 832-844
DOI: 10.1021/jacs.1c10504
Key words
OGA-inhibitors - chemoproteomic mapping - O-linked N-acetylglucosamine - Staudinger reduction - biotin
Significance
O-Linked N-acetylglucosamine (O-GlcNAc) is an important post-translational modification (PTM) that regulates many cellular processes. In contrast to numerous kinases and phosphatases controlling the phosphorylation state of the proteome, only two enzymes are responsible for O-GlcNAc installation (O-GlcNAc transferase, OGT) and removal (O-GlcNAcase, OGA). The regulation of OGA activity remains poorly understood despite a dysregulation being linked to various neurodegenerative diseases.
Comment
The authors developed a novel series of OGA inhibitors with picomolar binding affinity that are based on the aminosugar dideoxynojirimycin. Structural mimicry of the hydrolyzing transition state guided the search toward the bicyclic imino-thiazolidine scaffold. Furthermore, a biotin-conjugate was synthesized, which served as an affinity-purification tag and revealed new PTMs of OGA from brain cell tissue lysates. Both inhibitors and probes could serve as important tools to elucidate the regulatory mechanism of OGA.
Publikationsverlauf
Artikel online veröffentlicht:
18. März 2022
© 2022. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
